657 related articles for article (PubMed ID: 27098609)
1. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.
Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA
Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609
[TBL] [Abstract][Full Text] [Related]
2. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
3. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
4. Down regulation of Peroxiredoxin-3 in 3T3-L1 adipocytes leads to oxidation of Rictor in the mammalian-target of rapamycin complex 2 (mTORC2).
Olson DH; Burrill JS; Kuzmicic J; Hahn WS; Park JM; Kim DH; Bernlohr DA
Biochem Biophys Res Commun; 2017 Nov; 493(3):1311-1317. PubMed ID: 28986255
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide.
Festuccia WT; Pouliot P; Bakan I; Sabatini DM; Laplante M
PLoS One; 2014; 9(4):e95432. PubMed ID: 24740015
[TBL] [Abstract][Full Text] [Related]
6. Rictor/mTORC2 loss in the Myf5 lineage reprograms brown fat metabolism and protects mice against obesity and metabolic disease.
Hung CM; Calejman CM; Sanchez-Gurmaches J; Li H; Clish CB; Hettmer S; Wagers AJ; Guertin DA
Cell Rep; 2014 Jul; 8(1):256-71. PubMed ID: 25001283
[TBL] [Abstract][Full Text] [Related]
7. Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis.
Sanchez-Gurmaches J; Tang Y; Jespersen NZ; Wallace M; Martinez Calejman C; Gujja S; Li H; Edwards YJK; Wolfrum C; Metallo CM; Nielsen S; Scheele C; Guertin DA
Cell Metab; 2018 Jan; 27(1):195-209.e6. PubMed ID: 29153407
[TBL] [Abstract][Full Text] [Related]
8. Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling.
Zhang D; Tong X; Arthurs B; Guha A; Rui L; Kamath A; Inoki K; Yin L
J Biol Chem; 2014 Sep; 289(37):25925-35. PubMed ID: 25063808
[TBL] [Abstract][Full Text] [Related]
9. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
Tripathy S; Jump DB
J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.
Lamming DW; Ye L; Katajisto P; Goncalves MD; Saitoh M; Stevens DM; Davis JG; Salmon AB; Richardson A; Ahima RS; Guertin DA; Sabatini DM; Baur JA
Science; 2012 Mar; 335(6076):1638-43. PubMed ID: 22461615
[TBL] [Abstract][Full Text] [Related]
11. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
Herman MA; Peroni OD; Villoria J; Schön MR; Abumrad NA; Blüher M; Klein S; Kahn BB
Nature; 2012 Apr; 484(7394):333-8. PubMed ID: 22466288
[TBL] [Abstract][Full Text] [Related]
12. Pu'erh tea extract-mediated protection against hepatosteatosis and insulin resistance in mice with diet-induced obesity is associated with the induction of de novo lipogenesis in visceral adipose tissue.
Cai X; Hayashi S; Fang C; Hao S; Wang X; Nishiguchi S; Tsutsui H; Sheng J
J Gastroenterol; 2017 Dec; 52(12):1240-1251. PubMed ID: 28364190
[TBL] [Abstract][Full Text] [Related]
13. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
[TBL] [Abstract][Full Text] [Related]
15. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 1 ameliorates adipose tissue inflammation and systemic insulin resistance via enhancing adipocyte mTORC2/Rictor signal.
Zhao L; Fan M; Zhao L; Yun H; Yang Y; Wang C; Qin D
J Cell Mol Med; 2020 Nov; 24(21):12813-12825. PubMed ID: 32979037
[TBL] [Abstract][Full Text] [Related]
17. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
[TBL] [Abstract][Full Text] [Related]
18. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
[TBL] [Abstract][Full Text] [Related]
19. The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation.
Kowalsky AH; Namkoong S; Mettetal E; Park HW; Kazyken D; Fingar DC; Lee JH
J Biol Chem; 2020 Feb; 295(7):1769-1780. PubMed ID: 31915252
[TBL] [Abstract][Full Text] [Related]
20. Rictor in perivascular adipose tissue controls vascular function by regulating inflammatory molecule expression.
Bhattacharya I; Drägert K; Albert V; Contassot E; Damjanovic M; Hagiwara A; Zimmerli L; Humar R; Hall MN; Battegay EJ; Haas E
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2105-11. PubMed ID: 23868942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
